Re-evaluating statin activity in cancer.

doi:10.18632/aging.101504

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Re-evaluating statin activity in cancer.

Aging - 22 Jul 2018

Camacho Laura, Zabala-Letona Amaia, Carracedo Arkaitz

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dose-Response Relationship, Drug
Share to Genetic Predisposition to Disease
Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors
Share to Mice

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Obesity

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 30036187
DOI: 10.18632/aging.101504
PMCID: PMC6075430

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Re-evaluating statin activity in cancer.PMID 30036187Read ↗

The role of statins as therapeutic agents in cancerSemantic proximity Read ↗

Statin Responses in Chinese Patients.Semantic proximity Read ↗

Biomarker identification for statin sensitivity of cancer cell linesSemantic proximity Read ↗

Statins are potential anticancerous agents (Review)Semantic proximity Read ↗

Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study.Semantic proximity Read ↗

Identifying drug repositioning candidates for age-related outcomes in the Danish health registriesSemantic proximity Read ↗

Farnesyltransferase inhibitors versus Ras inhibitorsSemantic proximity Read ↗

Intolerance to statins: mechanisms and management.Semantic proximity Read ↗

Beyond statins: what to expect from add-on lipid regulating therapy?Semantic proximity Read ↗

Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.